- Home
- GALT vs PDEX Comparison
GALT vs PDEX Comparison
Compare GALT & PDEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GALT
- PDEX
- Stock Information
- Founded
- GALT 2000
- PDEX 1978
- Country
- GALT United States
- PDEX United States
- Employees
- GALT N/A
- PDEX N/A
- Industry
- GALT Biotechnology: Pharmaceutical Preparations
- PDEX Medical/Dental Instruments
- Sector
- GALT Health Care
- PDEX Health Care
- Exchange
- GALT Nasdaq
- PDEX Nasdaq
- Market Cap
- GALT 147.8M
- PDEX 161.1M
- IPO Year
- GALT N/A
- PDEX N/A
- Fundamental
- Price
- GALT $2.12
- PDEX $48.45
- Analyst Decision
- GALT Strong Buy
- PDEX Strong Buy
- Analyst Count
- GALT 1
- PDEX 1
- Target Price
- GALT $11.00
- PDEX $52.00
- AVG Volume (30 Days)
- GALT 549.5K
- PDEX 34.1K
- Earning Date
- GALT 11-13-2024
- PDEX 02-06-2025
- Dividend Yield
- GALT N/A
- PDEX N/A
- EPS Growth
- GALT N/A
- PDEX 1.56
- EPS
- GALT N/A
- PDEX 1.49
- Revenue
- GALT N/A
- PDEX $56,798,000.00
- Revenue This Year
- GALT N/A
- PDEX $15.56
- Revenue Next Year
- GALT N/A
- PDEX $3.28
- P/E Ratio
- GALT N/A
- PDEX $32.61
- Revenue Growth
- GALT N/A
- PDEX 21.01
- 52 Week Low
- GALT $1.56
- PDEX $16.18
- 52 Week High
- GALT $4.27
- PDEX $54.84
- Technical
- Relative Strength Index (RSI)
- GALT 39.78
- PDEX 53.12
- Support Level
- GALT $1.80
- PDEX $47.59
- Resistance Level
- GALT $2.36
- PDEX $49.84
- Average True Range (ATR)
- GALT 0.23
- PDEX 3.60
- MACD
- GALT -0.03
- PDEX -0.89
- Stochastic Oscillator
- GALT 26.89
- PDEX 35.06
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
About PDEX Pro-Dex Inc.
Pro-Dex Inc is engaged in the design, development, and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used in the orthopedic, thoracic, and craniomaxillofacial (CMF) markets. The company also designs and manufactures multi-axis motion control systems used in factory automation and scientific research markets. Majority of the company's revenue is derived from designing, developing, and manufacturing surgical devices for the medical device and dental industries.